NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹2.48 Cr | ₹2.19 Cr | ₹1.37 Cr | ₹1.91 Cr | ₹2.38 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of NGL FINECHEM ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2025 | ₹2.48 Cr |
Mar2024 | ₹2.19 Cr |
Mar2023 | ₹1.37 Cr |
Mar2022 | ₹1.91 Cr |
Mar2021 | ₹2.38 Cr |
How is Deferred Tax Assets / Liabilities of NGL FINECHEM Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹2.48 Cr | 12.85 | |
Mar2024 | ₹2.19 Cr | 60.15 | |
Mar2023 | ₹1.37 Cr | -28.20 | |
Mar2022 | ₹1.91 Cr | -19.76 | |
Mar2021 | ₹2.38 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹764.5 Cr | -6.4% | -2.9% | -51.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹383,570.0 Cr | -1.9% | -4.1% | -6.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,808.0 Cr | -3.6% | -12.3% | 27.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,734.0 Cr | -2.1% | 7.2% | 9.3% | Stock Analytics | |
CIPLA | ₹120,468.0 Cr | -0.7% | -0% | -2.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,212.0 Cr | -1.6% | -5.4% | -12.1% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | -6.4% |
-2.9% |
-51.1% |
SENSEX | -0.7% |
-3.7% |
2.4% |
You may also like the below Video Courses